HSIC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Henry Schein Inc (HSIC) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The company's stable financial growth, positive industry sentiment, and bullish technical indicators make it a solid choice for long-term investment.
The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200), with MACD histogram at 0.4 and positively contracting. RSI is neutral at 49.955, and the current price of $78.43 is near the pivot level of $77.865, with resistance levels at $81.578 and $83.872. This suggests a potential upward trend.
Positive sentiment from analysts, with Mizuho raising the price target to $81 and Barclays initiating coverage with an Overweight rating and an $86 price target.
Financial growth in Q3 2025, with revenue up 5.20% YoY and EPS up 6.41% YoY.
The American Dental Association's Give Kids A Smile program highlights Henry Schein's involvement in impactful initiatives, which may enhance brand reputation.
Gross margin dropped by 1.98% YoY in Q3 2025, which could indicate cost pressures.
No significant insider or hedge fund trading trends, suggesting a lack of strong institutional conviction.
In Q3 2025, revenue increased by 5.20% YoY to $3.34 billion, net income rose by 2.02% YoY to $101 million, and EPS grew by 6.41% YoY to $0.83. However, gross margin declined by 1.98% YoY to 28.69%. Overall, the financial performance indicates steady growth with minor cost-related challenges.
Mizuho raised the price target to $81 from $74 and maintained a Neutral rating, citing a positive dental industry outlook. Barclays initiated coverage with an Overweight rating and an $86 price target, showing bullish sentiment on the stock. Analysts are optimistic about the dental and healthcare technology sectors.
